PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB)

1.78 0.02 (1.14%)

As of 2025-10-16 18:59:30 EST

Pacific Biosciences of California, Inc. (aka PacBio) is an American biotechnology company founded in 2004 that develops and manufactures systems for gene sequencing and some novel real time biological observation. PacBio has two principal sequencing platforms: single-molecule real-time sequencing (SMRT), based on the properties of zero-mode waveguides and sequencing by binding (SBB) chemistry, which uses native nucleotides and scarless incorporation for DNA binding and extension.

Traded asNasdaq: PACB
ISINUS69404D1081
CIK0001299130
LEI529900F1BWRE1M0KZN89
EIN161590339
Sector—
IndustryLaboratory Analytical Instruments
CEOChristian Henry
Employees575
Fiscal Year End1231
Address1305 O'BRIEN DRIVE, MENLO PARK, CA, 94025
Phone650-521-8000
Websitehttp://pacb.com
Stock Quotes
trading_symbolregistrant_nametimepricechangepercentage_change
PACBPACIFIC BIOSCIENCES OF CALIFORNIA, INC.2025-10-16 18:59:301.780.021.14
This is a preview of the latest data. Subscribe to access the full data.
Company Information
trading_symbolcentral_index_keyregistrant_nameisin_numberlei_numberein_numberexchangesic_codesic_descriptionfiscal_year_endstate_of_incorporationaddress_streetaddress_cityaddress_stateaddress_zip_codeaddress_countryaddress_country_codephone_numbermailing_addressbusiness_addressformer_nameindustryfounding_datechief_executive_officernumber_of_employeeswebsitemarket_capshares_issuedshares_outstandingdescriptionupdate_time
PACB0001299130PACIFIC BIOSCIENCES OF CALIFORNIA, INC.US69404D1081529900F1BWRE1M0KZN89161590339Nasdaq3826Laboratory Analytical Instruments1231DE1305 O'BRIEN DRIVEMENLO PARKCA94025UNITED STATESUS650-521-80001305 O'BRIEN DRIVE, MENLO PARK, CA, 940251305 O'BRIEN DRIVE, MENLO PARK, CA, 94025PACIFIC BIOSCIENCES OF CALIFORNIA INC—2004Christian Henry575http://pacb.com371,400,000300,350,000300,370,611Pacific Biosciences of California, Inc. (aka PacBio) is an American biotechnology company founded in 2004 that develops and manufactures systems for gene sequencing and some novel real time biological observation. PacBio has two principal sequencing platforms: single-molecule real-time sequencing (SMRT), based on the properties of zero-mode waveguides and sequencing by binding (SBB) chemistry, which uses native nucleotides and scarless incorporation for DNA binding and extension.2025-10-10 21:58:49
This is a preview of the latest data. Subscribe to access the full data.
PACB Stock Price (End-of-Day)
This is a preview of the latest data. Subscribe to access the full data.
PACB Stock Price (1-Minute)
This is a preview of the latest data. Subscribe to access the full data.
Market Cap
Fiscal YearMarket CapChange In Market CapPercentage Change In Market CapShares OutstandingChange In Shares OutstandingPercentage Change In Shares Outstanding
2024371,400,000-2,952,301,933-88.8257297,852,22829,900,34811.1588
20233,323,701,9332,331,833,424235.095267,951,88020,872,5068.4477
2022991,868,509-5,799,219,635-85.3946247,079,37425,896,91711.7084
This is a preview of the latest data. Subscribe to access the full data.
Executive Compensation
Executive NameExecutive PositionFiscal YearSalaryBonusStock AwardsIncentive Plan CompensationOther CompensationTotal Compensation
Mark Van OeneChief Operating Officer2024601,97404,094,130108,90004,805,004
Jeff EidelChief Commercial Officer2024420,20802,367,6900545,2693,333,167
Christian O. HenryChief Executive Officer, President2024725,02508,237,595219,00009,181,620
Susan G. KimChief Financial Officer2024449,74302,219,710002,669,453
Jeff EidelChief Commercial Officer2023456,33301,832,108230,00015,2862,533,727
This is a preview of the latest data. Subscribe to access the full data.
Employee Count
Fiscal YearEmployee Count
2024575
2023796
2022769
This is a preview of the latest data. Subscribe to access the full data.
Income Statements
Fiscal Year202420232022
Revenue154,014,000200,521,000128,304,000
Cost Of Revenue116,732,000147,741,00079,269,000
Gross Profit37,282,00052,780,00049,035,000
Research And Development Expenses134,922,000187,170,000193,000,000
General And Administrative Expenses175,017,000169,818,000160,854,000
Operating Expenses511,595,000387,247,000356,231,000
Operating Income-474,313,000-334,467,000-307,196,000
Net Income-309,851,000-306,735,000-314,248,000
Earnings Per Share Basic-1.13-1.21-1.4
Earnings Per Share Diluted-1.59-1.21-1.4
Weighted Average Shares Outstanding Basic274,488,000253,629,000224,550,000
Weighted Average Shares Outstanding Diluted288,366,000253,629,000224,550,000
This is a preview of the latest data. Subscribe to access the full data.
Balance Sheet Statements
Fiscal Year202420232022
Cash And Cash Equivalents55,370,000179,911,000325,089,000
Marketable Securities Current334,561,000465,181,000564,752,000
Accounts Receivable27,524,00036,615,00018,786,000
Inventories58,755,00056,676,00050,381,000
Non Trade Receivables———
Other Assets Current———
Total Assets Current495,681,000742,047,000852,074,000
Marketable Securities Non Current—96,063,00069,930,000
Property Plant And Equipment30,505,00036,432,00041,580,000
Other Assets Non Current9,305,00013,274,00010,528,000
Total Assets Non Current764,766,0001,003,966,000915,012,000
Total Assets1,260,447,0001,746,013,0001,767,086,000
Accounts Payable16,590,00015,062,00012,028,000
Deferred Revenue13,864,00016,342,00030,498,000
Short Term Debt0490,0001,842,000
Other Liabilities Current3,224,0008,326,0007,233,000
Total Liabilities Current66,299,00095,029,000263,335,000
Long Term Debt435,494,000490,000896,683,000
Other Liabilities Non Current546,000751,0001,300,000
Total Liabilities Non Current687,554,000949,680,000940,847,000
Total Liabilities753,853,0001,044,709,0001,204,182,000
Common Stock294,000268,000227,000
Retained Earnings-2,148,926,000-1,839,075,000-1,532,340,000
Accumulated Other Comprehensive Income422,000219,000-4,765,000
Total Shareholders Equity506,594,000701,304,000562,904,000
This is a preview of the latest data. Subscribe to access the full data.
Cash Flow Statements
Fiscal Year202420232022
Depreciation And Amortization27,400,0008,300,0009,480,000
Share Based Compensation Expense71,036,00072,118,00078,613,000
Other Non Cash Income Expense628,000—-278,000
Change In Accounts Receivable-9,091,00017,829,000-5,455,000
Change In Inventories8,320,00013,841,00033,906,000
Change In Non Trade Receivables———
Change In Other Assets———
Change In Accounts Payable1,405,000206,0001,025,000
Change In Other Liabilities-4,612,00013,103,000-3,651,000
Cash From Operating Activities-206,058,000-259,173,000-263,211,000
Purchases Of Marketable Securities498,635,000756,567,000442,788,000
Sales Of Marketable Securities34,856,000595,000575,800,000
Acquisition Of Property Plant And Equipment6,188,0008,843,00016,750,000
Acquisition Of Business0102,000—
Other Investing Activities———
Cash From Investing Activities124,004,0004,604,000116,083,000
Tax Withholding For Share Based Compensation———
Payments Of Dividends———
Issuance Of Common Stock015,319,00011,230,000
Repurchase Of Common Stock———
Issuance Of Long Term Debt———
Repayment Of Long Term Debt———
Other Financing Activities7,703,0000—
Cash From Financing Activities-42,987,000108,891,0009,622,000
Change In Cash-125,041,000-145,678,000-137,506,000
Cash At End Of Period55,370,000179,911,000325,089,000
Income Taxes Paid———
Interest Paid14,805,00015,687,00014,049,000
This is a preview of the latest data. Subscribe to access the full data.
Key Metrics
Fiscal Year202420232022
Earnings Per Share-1.13-1.21-1.4
Price To Earnings Ratio-1.6195-8.1074-5.8429
Earnings Growth Rate-6.6116-13.571457.3034
Price Earnings To Growth Ratio0.24490.5974-0.102
Book Value Per Share1.84562.76512.5068
Price To Book Ratio0.99153.54783.2631
Ebitda-269,039,000-284,092,000-290,078,000
Enterprise Value882,437,0402,309,169,4902,410,255,000
Dividend Yield———
Dividend Payout Ratio———
Debt To Equity Ratio0.85970.00141.5962
Capital Expenditures21,473,0003,152,00018,556,000
Free Cash Flow-227,531,000-262,325,000-281,767,000
Return On Equity-0.6116-0.4374-0.5583
One Year Beta2.92752.31572.8758
Three Year Beta2.76092.73841.8625
Five Year Beta1.97031.77881.5956
This is a preview of the latest data. Subscribe to access the full data.
Insider Transactions
Insider NameRelationship To IssuerTransaction DateAmount Of SecuritiesAcquired Or DisposedSecurities Owned Following Transaction
Van Oene Mark—2025-08-1826,836D1,920,035
Smith Christopher MDirector2025-06-0432,500A32,500
Valantine HannahDirector2025-06-0465,000A65,000
MILLIGAN JOHN FDirector2025-06-0465,000A65,000
Ericson William W.Director2025-06-0465,000A65,000
This is a preview of the latest data. Subscribe to access the full data.
Institutional Holdings
Investor NamePeriod Of ReportMarket ValueAmount Of SecuritiesPrice Per Security
CWM, LLC2025-09-305,0004,1401.2077
Green Alpha Advisors, LLC2025-09-30222,752174,0251.28
Tactive Advisors, LLC2025-09-3018,53814,4831.28
Farther Finance Advisors, LLC2025-09-301511181.2797
AdvisorNet Financial, Inc2025-09-30161,046125,8171.28
This is a preview of the latest data. Subscribe to access the full data.
Mutual Fund Holdings
Registrant NamePeriod Of ReportFund NameFund SymbolAmount Of UnitsValue In UsdPercentage Value Compared To Assets
Advisors' Inner Circle Fund III2025-07-31I SharesKCXIX1,3111,809.180.0007
INVESCO EXCHANGE-TRADED FUND TRUST2025-07-31Invesco RAFI US 1500 Small-Mid ETFPRFZ675,058931,580.040.0393
Global X Funds2025-07-31Global X Russell 2000 ETFRSSL139,873193,024.740.0147
FIDELITY CONCORD STREET TRUST2025-07-31Fidelity ZERO Total Market Index FundFZROX135,537187,041.060.0007
FIDELITY CONCORD STREET TRUST2025-07-31Fidelity ZERO Extended Market Index FundFZIPX83,778115,613.640.0063
This is a preview of the latest data. Subscribe to access the full data.